← All FR Documents
Notice

National Cancer Institute; Notice of Partially Closed Meetings

📖 Research Context From Federal Register API

Key Dates
Citation: 90 FR 14141
July 7, 2025.
Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

July 7, 2025.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-05374
FR Citation90 FR 14141
TypeNotice
PublishedMar 28, 2025
Effective Date-
RIN-
Docket ID-
Pages14141–14142 (2 pages)
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (632 words · ~4 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>National Cancer Institute; Notice of Partially Closed Meetings</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the Board of Scientific Counselors, National Cancer Institute. The meeting will be held as a virtual meeting and is partially open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocast at the following link: <E T="03">http://videocast.nih.gov/</E> . The meetings will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Cancer Institute, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> Board of Scientific Counselors, National Cancer Institute. <E T="03">Date:</E> July 7, 2025. <E T="03">Open:</E> 10:00 a.m. to 10:40 a.m. <E T="03">Agenda:</E> Remarks from the NCI Director. <E T="03">Closed:</E> 11:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> Personnel qualifications and performance, and competence of individual investigators. <E T="03">Address:</E> National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Name of Committee:</E> Board of Scientific Counselors, National Cancer Institute. <E T="03">Date:</E> July 8, 2025. <E T="03">Closed:</E> 10:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> Personnel qualifications and performance, and competence of individual investigators. <E T="03">Address:</E> National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Brian E. Wojcik, Ph.D., Senior Review Administrator, Institute Review Office, Office of the Director, National Cancer Institute, 9609 Medical Center Drive, Room 3W414, Bethesda, MD 20892, 240-276-5665, <E T="03">wojcikb@mail.nih.gov</E> . <E T="03">Name of Committee:</E> Board of Scientific Counselors, National Cancer Institute. <E T="03">Date:</E> November 3, 2025. <E T="03">Open:</E> 10:00 a.m. to 10:30 a.m. <E T="03">Agenda:</E> Remarks from the NCI Director. <E T="03">Closed:</E> 11:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> Personnel qualifications and performance, and competence of individual investigators. <E T="03">Address:</E> National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Name of Committee:</E> Board of Scientific Counselors, National Cancer Institute. <E T="03">Date:</E> November 4, 2025. <E T="03">Closed:</E> 10:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> Personnel qualifications and performance, and competence of individual investigators. <E T="03">Address:</E> National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Brian E. Wojcik, Ph.D., Senior Review Administrator, Institute Review Office, Office of the Director, National Cancer Institute, 9609 Medical Center Drive, Room 3W414, Bethesda, MD 20892, 240-276-5665, <E T="03">wojcikb@mail.nih.gov</E> . Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute's/Center's home page: <E T="03">https://deainfo.nci.nih.gov/advisory/bsc/index.htm,</E> where an agenda and any additional information for the meeting will be posted when available. <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: March 25, 2025.</DATED> <NAME>Melanie J. Pantoja,</NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-05374 Filed 3-27-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.